Indian pharma is gaining a stronger foothold in Nigeria as bilateral economic ties expand and companies deepen their presence across Africa
Gujarat is drawing fresh pharma investment worth INR 2,500-3,000 crore. The money is going into new drug manufacturing facilities across the state. The investment follows approvals for 59 new allopathic medicine plants during FY2025-26.
Gland Pharma reported a strong Q1 profit. The company posted revenue of INR 1,800.27 crore in Q1 FY27. Its net profit rose 47.1% year over year to INR 316.95 crore.
India’s TB screening drive has uncovered a major number of cases, highlighting the scale of hidden tuberculosis. More than 2.2 crore people were screened during the 100-day campaign, with over 7 lakh TB cases detected. Union Health Minister...
Pharma exports, drug regulation, and rare disease therapies are signaling a broader shift across the pharmaceutical sector
Fertility drug regulation has come under scrutiny after the Central Drugs Standard Control Organization flagged the unauthorized manufacture
Ebola outbreak developments in the Democratic Republic of Congo have taken another serious turn, with confirmed cases rising to 4,449 and deaths reaching 2,061
The oral semaglutide race in India has hit a fresh legal hurdle. The Delhi High Court has asked Sun Pharma to seek its approval before launching the tablets.
.jpg "Hyderabad Gets a Major Boost as Amgen Plans New R&D Center")
Hyderabad is set for a major boost as Amgen plans a new R&D center in the city. The center will strengthen the company’s research capabilities in India. It will also expand Hyderabad’s role in global drug research and innovation.
The latest developments across drug regulation, R&D, and healthcare expansion signal important shifts in the global and Indian pharmaceutical industry
, CDSCO.jpg "Fostering a Quality Culture in the Pharmaceutical Industry")